UNSPSC 51263124: Indopanolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2JQ3661CAD. European Medicines Agency schedules Indopanolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08181MIG. Indopanolol generally arises in the molecular formula C20H23CLN2O3.

UNSPSC 51263124 Indopanolol is a Commodity code with no meaningful recent state and local procurement activity. The two opportunities posted under this code in the source—Seminole County's July 2026 IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's April 2026 RFI on direct-to-manufacturer prescription programs—do not align with the code's nominal scope (indopanolol, a specific beta-blocker pharmaceutical). State and local procurement officers appear to be tagging pharmaceutical-related solicitations with this code regardless of the actual active ingredient or therapeutic class being procured, suggesting either classification drift or jurisdictional tagging practices that do not enforce code precision. Indopanolol itself does not appear in either solicitation; the actual products being sourced are naloxone (an opioid antagonist) and generic prescription fulfillment capabilities unrelated to indopanolol's cardiovascular indications.

The code shows insufficient targeted activity to support reliable business development planning. If your firm manufactures or distributes indopanolol for state or local health agencies, monitor the code for future opportunities, but do not rely on the current opportunities as indicators of demand for this product. The mismatch between code and scope means that relevant indopanolol solicitations may be tagged under different UNSPSC codes or listed under pharmaceutical family codes with broader scope.